Astria Therapeutics (ATXS) PT Lowered to $25 at Citizens JMP
Tweet Send to a Friend
Citizens JMP analyst Jonathan Wolleben lowered the price target on Astria Therapeutics (NASDAQ: ATXS) to $25.00 (from $26.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
